If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
249.50    0.50 (0.20%)
Bid:
245.50
Ask:
251.50
Spread: 6.00 (2.444%)
Market Cap: £145.55m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Holding(s) in Company

16 Dec 2015 08:19

RNS Number : 2279J
MJ Gleeson PLC
16 December 2015
 

 

 

 

 

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

 

 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

MJ Gleeson PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

No

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

No

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

No

An event changing the breakdown of voting rights

No

Other (please specify):

Discretionary votes lodged in respect of the Company's Annual General Meeting on 11 December 2015. Discretion has been given to the Chairman of the meeting.

Yes

3. Full name of person(s) subject to thenotification obligation: iii

Dermot Gleeson. Chairman of MJ Gleeson PLC (Proxy holder)

4. Full name of shareholder(s) (if different from 3.):iv

 

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

9 December 2015

6. Date on which issuer notified:

11 December 2015

7. Threshold(s) that is/are crossed orreached: vi, vii

9% and 12%

      

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

ISIN

GB00BRKD9Z53

Ord shares of 2p each

Resolution 1

1,063,945

1,063,945

1,063,945

3,932,467

1.96

7.27

 

Resolution 2

1,063,945

1,063,945

1,063,945

3,932,467

1.96

7.27

 

Resolution 3

1,063,945

1,063,945

1,063,945

3,934,852

1.96

7.27

 

Resolution 4

1,063,945

1,063,945

1,063,945

3,934,117

1.96

7.27

 

Resolution 5

1,063,945

1,063,945

1,063,945

3,934,852

1.96

7.27

 

Resolution 6

1,063,945

1,063,945

1,063,945

3,934,852

1.96

7.27

 

Resolution 7

1,063,945

1,063,945

1,063,945

3,934,852

1.96

7.27

 

Resolution 8

1,063,945

1,063,945

1,063,945

3,934,852

1.96

7.27

 

Resolution 9

1,063,945

1,063,945

1,063,945

3,933,202

1.96

7.27

 

Resolution 10

1,063,945

1,063,945

1,063,945

3,933,202

1.96

7.27

 

Resolution 11

1,063,945

1,063,945

1,063,945

3,933,142

1.96

7.27

 

Resolution 12

1,063,945

1,063,945

1,063,945

5,590,770

1.96

10.33

 

Resolution 13

1,063,945

1,063,945

1,063,945

5,589,770

1.96

10.33

 

Resolution 14

1,063,945

1,063,945

1,063,945

5,590,840

1.96

10.33

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

 

 

 

 

 

            

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

Resolution 1 4,996,412

9.23

Resolution 2 4,996,412

9.23

Resolution 3 4,998,797

9.24

Resolution 4 4,998,062

9.23

Resolution 5 4,998,797

9.24

Resolution 6 4,998,797

9.24

Resolution 7 4,998,797

9.24

Resolution 8 4,998,797

9.24

Resolution 9 4,997,147

9.23

Resolution 10 4,997,147

9.23

Resolution 11 4,997,087

9.23

Resolution 12 6,654,715

12.30

Resolution 13 6,653,715

12.29

Resolution 14 6,654,785

12.30

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

 

Proxy Voting:

10. Name of the proxy holder:

Dermot Gleeson

11. Number of voting rights proxy holder will ceaseto hold:

Resolution 1

3,932,467

7.27%

Resolution 2

3,932,467

7.27%

Resolution 3

3,934,852

7.27%

Resolution 4

3,934,117

7.27%

Resolution 5

3,934,852

7.27%

Resolution 6

3,934,852

7.27%

Resolution 7

3,934,852

7.27%

Resolution 8

3,934,852

7.27%

Resolution 9

3,933,202

7.27%

Resolution 10

3,933,202

7.27%

Resolution 11

3,933,142

7.27%

Resolution 12

5,590,770

10.33%

Resolution 13

5,589,770

10.33%

Resolution 14

5,590,840

10.33%

12. Date on which proxy holder will cease to holdvoting rights:

On the conclusion of the Annual General Meeting (i.e. on 11 December 2015 or later if the meeting is adjourned)

13. Additional information:

Calculation based on total voting rights of 54,120,495

14. Contact name:

Stefan Allanson, Chief Financial Officer

15. Contact telephone number:

01142 612900

 

      

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLVQLBFELFFFBD
Date   Source Headline
9th Jun 20262:17 pmRNSDirector/PDMR Shareholding
9th Jun 20267:00 amRNSUpdate on Gleeson Land
2nd Jun 20267:00 amRNSBoard Committee Changes
7th May 20264:36 pmRNSDirector/PDMR Shareholding
7th May 20262:49 pmRNSDirector/PDMR Shareholding
1st May 20267:00 amRNSTrading Update
23rd Apr 20267:00 amRNSNotice of Trading Updates and FY2026 Results
14th Apr 20269:34 amRNSDirector/PDMR Shareholding
14th Apr 20269:33 amRNSDirector/PDMR Shareholding
6th Mar 20263:19 pmRNSDirector/PDMR Shareholding
2nd Mar 20264:04 pmRNSHolding(s) in Company
11th Feb 20267:00 amRNSResults for the half year ended 31 December 2025
9th Feb 202610:47 amRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNS-RPresentation of HY Results on Engage Investor
16th Jan 20267:00 amRNSTrading Update and Notice of Results
6th Jan 20264:40 pmRNSDirector/PDMR Shareholding
9th Dec 202511:31 amRNSDirector/PDMR Shareholding
25th Nov 20251:01 pmRNSDirector/PDMR Shareholding
20th Nov 20253:25 pmRNSHolding(s) in Company
14th Nov 20252:46 pmRNSResult of AGM
14th Nov 20257:01 amRNSAppointment of Non-Executive Director
14th Nov 20257:00 amRNSAGM Trading Update
6th Nov 20255:09 pmRNSDirector/PDMR Shareholding
24th Oct 20254:16 pmRNSDirector/PDMR Shareholding
23rd Oct 20255:07 pmRNSDirector/PDMR Shareholding
20th Oct 20254:09 pmRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSNotice of AGM
7th Oct 20253:18 pmRNSDirector/PDMR Shareholding
22nd Sep 20255:01 pmRNSREPLACEMENT: Director/PDMR Shareholding
18th Sep 20257:00 amRNS-RPresentation on Engage Investor Platform
17th Sep 20254:23 pmRNSDirector/PDMR Shareholding
16th Sep 20257:00 amRNSAudited results for the year ended 30 June 2025
9th Sep 202510:45 amRNSDirector/PDMR Shareholding
13th Aug 20257:00 amRNSNotice of Full-Year Results and Presentation
7th Aug 20253:05 pmRNSDirector/PDMR Shareholding
10th Jul 20254:17 pmRNSDirector/PDMR Shareholding
9th Jul 20251:05 pmRNSHolding(s) in Company
8th Jul 20254:00 pmRNSDirector/PDMR Shareholding
7th Jul 20253:11 pmRNSHolding(s) in Company
4th Jul 20257:00 amRNSDirectorate Change
4th Jul 20257:00 amRNSTrading Statement
12th Jun 20253:21 pmRNSDirector/PDMR Shareholding
10th Jun 202511:34 amRNSDirector/PDMR Shareholding
6th Jun 20257:00 amRNSHolding(s) in Company
4th Jun 20255:06 pmRNSDirector/PDMR Shareholding
3rd Jun 20257:03 amRNSTrading Update
7th May 20252:33 pmRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSDirectorate Change
8th Apr 20255:22 pmRNSDirector/PDMR Shareholding
8th Apr 20255:17 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.